UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (17897) 17897
Book Chapter (79) 79
Dissertation (31) 31
Conference Proceeding (28) 28
Magazine Article (22) 22
Book / eBook (11) 11
Newspaper Article (9) 9
Publication (6) 6
Book Review (2) 2
Web Resource (2) 2
Government Document (1) 1
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (7824) 7824
humans (6913) 6913
life sciences & biomedicine (6666) 6666
pyrazine derivatives (4855) 4855
pyrazines - pharmacology (4633) 4633
animals (4143) 4143
male (4029) 4029
bortezomib (3906) 3906
pyrazines - therapeutic use (3109) 3109
female (2980) 2980
biological and medical sciences (2657) 2657
medical sciences (2230) 2230
middle aged (2086) 2086
pyrazines - administration & dosage (2045) 2045
chemistry (1857) 1857
oncology (1835) 1835
aged (1600) 1600
adult (1581) 1581
physical sciences (1566) 1566
boronic acids - therapeutic use (1538) 1538
pyrazines (1478) 1478
boronic acids - pharmacology (1477) 1477
multiple myeloma - drug therapy (1477) 1477
rats (1468) 1468
pharmacology & pharmacy (1413) 1413
pyrazines - chemistry (1404) 1404
mice (1395) 1395
boronic acids - administration & dosage (1235) 1235
hematology (1192) 1192
ring closure reactions (1185) 1185
pharmacology. drug treatments (1173) 1173
pyrazines - adverse effects (1096) 1096
cell line, tumor (1092) 1092
pyrazine (1040) 1040
antineoplastic agents - therapeutic use (1031) 1031
treatment outcome (1031) 1031
antineoplastic agents - pharmacology (1010) 1010
multiple myeloma (964) 964
apoptosis - drug effects (932) 932
antineoplastic combined chemotherapy protocols - therapeutic use (892) 892
biochemistry & molecular biology (876) 876
dose-response relationship, drug (845) 845
analysis (842) 842
sitagliptin phosphate (778) 778
pyrazines - chemical synthesis (725) 725
apoptosis (683) 683
boronic acids - adverse effects (671) 671
proteasome inhibitors (657) 657
research (638) 638
cancer (636) 636
abridged index medicus (612) 612
tumors (595) 595
rats, sprague-dawley (575) 575
pharmacology, medicinal chemistry, vaccines, serums (568) 568
antineoplastic agents (556) 556
care and treatment (553) 553
fundamental and applied biological sciences. psychology (553) 553
structure-activity relationship (545) 545
diabetes mellitus, type 2 - drug therapy (541) 541
molecular structure (540) 540
heterocyclic compounds (528) 528
time factors (528) 528
hematologic and hematopoietic diseases (506) 506
pyrazines - metabolism (494) 494
drug therapy, combination (477) 477
protease inhibitors - pharmacology (471) 471
aged, 80 and over (470) 470
cell proliferation - drug effects (467) 467
chemistry, multidisciplinary (466) 466
triazoles - therapeutic use (460) 460
multiple myeloma - pathology (456) 456
leukemias. malignant lymphomas. malignant reticulosis. myelofibrosis (449) 449
protease inhibitors - therapeutic use (448) 448
dexamethasone - administration & dosage (443) 443
endocrinology & metabolism (431) 431
pyrazines - pharmacokinetics (426) 426
drug synergism (422) 422
cell biology (409) 409
thalidomide - analogs & derivatives (409) 409
chemotherapy (407) 407
antineoplastic agents - adverse effects (406) 406
in vitro techniques (405) 405
clinical trials as topic (404) 404
drug therapy (399) 399
immunopathology (399) 399
immunodeficiencies. immunoglobulinopathies (392) 392
immunoglobulinopathies (391) 391
proteins (382) 382
organic chemistry (373) 373
hypoglycemic agents - therapeutic use (367) 367
chemistry, medicinal (361) 361
proteasome endopeptidase complex - metabolism (357) 357
antineoplastic agents - administration & dosage (356) 356
disease models, animal (356) 356
thalidomide - administration & dosage (348) 348
medicine & public health (345) 345
cells, cultured (339) 339
food science & technology (337) 337
health aspects (334) 334
pyridine derivatives (333) 333
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (17180) 17180
Chinese (480) 480
Japanese (282) 282
German (165) 165
French (155) 155
Italian (148) 148
Russian (67) 67
Spanish (49) 49
Polish (48) 48
Czech (28) 28
Portuguese (20) 20
Hungarian (14) 14
Dutch (11) 11
Danish (7) 7
Swedish (7) 7
Korean (6) 6
Slovak (5) 5
Norwegian (4) 4
Turkish (4) 4
Hebrew (3) 3
Finnish (2) 2
Romanian (2) 2
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 08/2012, Volume 120, Issue 8, pp. 1589 - 1596
Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Immunopathology | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Immunoglobulinopathies | Medical sciences | Immunodeficiencies. Immunoglobulinopathies | Boronic Acids - toxicity | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Pyrazines - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Boronic Acids - adverse effects | Dexamethasone - adverse effects | Dexamethasone - toxicity | Induction Chemotherapy | Male | Transplantation, Autologous | Antineoplastic Agents - therapeutic use | Pyrazines - therapeutic use | Antineoplastic Agents - administration & dosage | Boronic Acids - therapeutic use | Antineoplastic Agents - toxicity | Multiple Myeloma - therapy | Pyrazines - toxicity | Antineoplastic Agents - adverse effects | Female | Boronic Acids - administration & dosage | Thalidomide - adverse effects | Bortezomib | Dexamethasone - administration & dosage | Multiple Myeloma - diagnosis | Thalidomide - administration & dosage | Thalidomide - toxicity | Antineoplastic Combined Chemotherapy Protocols - toxicity | Disease-Free Survival | Dexamethasone - therapeutic use | Multiple Myeloma - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Pyrazines - adverse effects | Stem Cells - drug effects | Stem Cells - pathology | Aged | Hematopoietic Stem Cell Transplantation - methods | Thalidomide - therapeutic use | Index Medicus | Abridged Index Medicus
Journal Article
Journal of medicinal chemistry, ISSN 0022-2623, 09/2016, Volume 59, Issue 17, pp. 7773 - 7782
Journal Article
Russian journal of organic chemistry, ISSN 1070-4280, 02/2020, Volume 56, Issue 2, pp. 225 - 233
Journal Article
The New England journal of medicine, ISSN 0028-4793, 07/2015, Volume 373, Issue 3, pp. 232 - 242
Journal Article
Journal Article
The lancet oncology, ISSN 1470-2045, 2017, Volume 18, Issue 8, pp. 1061 - 1075
Journal Article
The New England journal of medicine, ISSN 0028-4793, 01/2016, Volume 374, Issue 4, pp. 323 - 332
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Recurrence | Benzamides - pharmacokinetics | Humans | Middle Aged | Pyrazines - administration & dosage | Male | Antineoplastic Agents - administration & dosage | Leukemia, Lymphocytic, Chronic, B-Cell - genetics | Protein Kinase Inhibitors - adverse effects | Diarrhea - chemically induced | Dose-Response Relationship, Drug | Benzamides - administration & dosage | Antineoplastic Agents - adverse effects | Female | Antineoplastic Agents - pharmacokinetics | Benzamides - adverse effects | Headache - chemically induced | Chromosome Deletion | Protein Kinase Inhibitors - pharmacokinetics | Administration, Oral | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Agammaglobulinaemia Tyrosine Kinase | Pyrazines - pharmacokinetics | Pyrazines - adverse effects | Aged | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Protein-Tyrosine Kinases - antagonists & inhibitors | Antimitotic agents | Treatment outcome | Usage | Care and treatment | Safety and security measures | Lymphocytic leukemia | Analysis | Clinical trials | Pharmacology | Dosage and administration | Pharmacokinetics | Antineoplastic agents | Tyrosine | Headache | Pharmacodynamics | Transformation | Chronic lymphatic leukemia | Inhibitor drugs | Leukemia | Diarrhea | Chromosome deletion | Lymphatic leukemia | Kinases | Lymphoma | Bruton's tyrosine kinase | Patients | Clonal deletion | Safety | Drug therapy | Lymphocytosis | Protein-tyrosine kinase | Chromosome 17 | Index Medicus | Abridged Index Medicus
Journal Article